Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rift Valley fever virus (RVFV) encodes two major glycoproteins, Gn and Gc, which are the principal viral antigens present on the surface of the virion. These glycoproteins play essential roles in viral entry by mediating host cell receptor binding and membrane fusion. They are key targets for diagnostics and vaccine development. Gc acts as a class II fusion protein activated upon acidification, facilitating viral-host membrane fusion during entry.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rift Valley Fever Virus Glycoproteins Gn and Gc (RVFV Gn/Gc).